Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET EARLY CALL: Markets Buoyed By US Stimulus Progress

Mon, 08th Feb 2021 07:02

(Alliance News) - Stock prices in London are seen opening higher at the start of the week, with the mood in global markets lifted by hopes for a new US stimulus package.

US President Joe Biden seized on feeble US employment data, published on Friday, to argue the world's largest economy needs his USD1.9 trillion pandemic relief package, which cleared a key Senate hurdle without support from the Republican opposition.

"I believe the American people are looking right now to their government for help," Biden said after a meeting with top Democratic lawmakers. "So I'm going to act. I'm going to act fast."

IG futures indicate the FTSE 100 index is to open 40.2 points higher at 6,529.53 on Monday. The blue-chip index closed down 0.2%, or 14.39 points at 6,489.33 on Friday.

"At the back end of last week, the Biden administration put in motion a plan to get the USD1.9 trillion stimulus package signed off without support from Republican lawmakers. President Biden has a history of fostering good relations with politicians from across the aisle as well as seeking consensus on issues but this time he is determined to put the American people first," CMC Markets analyst David Madden said.

"The stimulus move also helped US equities notch up a record close. Janet Yellen, the US treasury secretary, claimed the US economy could return to full employment next year if President Biden's USD1.9 trillion relief package is passed. The positive sentiment from the US at the end of last week helped Asian equity markets. European stock markets are on track for a positive start."

On Friday, the Dow Jones Industrial Average closed up 0.3%, the S&P 500 up 0.4%, and the Nasdaq Composite up 0.6%.

The Japanese Nikkei 225 index jumped 2.2% on Monday, closing above the 29,000 mark. In China, the Shanghai Composite was 0.9% higher in late trade, while the Hang Seng index in Hong Kong is up 0.3%.

"Chinese has released anti-monopoly news today, aimed squarely at China big-tech companies. Markets seem to have priced this in for now though, with mainland markets slightly higher and large Hong Kong-listed China technology companies outperforming there this morning," OANDA Asia Pacific Senior Market Analyst Jeffrey Halley said.

Tencent Holdings shares were 1.0% higher in Hong Kong.

In Sydney, the ASX 200 closed up 0.6%.

Sterling was trading at USD1.3726 on Monday morning, largely flat from USD1.3728 at the London equities close on Friday.

CMC's Madden added: "The UK continues to be one of the best countries in the world as far as the vaccination rollout is concerned, approximately 17% of the population have received their first jab of the vaccine. It is not all good news on the health front though, the AstraZeneca-Oxford vaccine is not effective against the South African strain of the coronavirus."

South Africa has temporarily suspended the AstraZeneca and Oxford University jab against a new variant found in the country, according to the health department and top local scientists.

The AstraZeneca-Oxford vaccine protects against the original Covid-19 strain, but its efficacy drops off substantially when it comes to the new variant called B.1.351 or 501.V2, raising serious concerns, said Shabir Madhi, the professor of vaccinology at the University of the Witwatersrand, citing a new local study involving 2,000 participants.

The euro stood at USD1.2033 on Monday morning London time, up from USD1.2025 at the European equities close on Friday. Against the yen, the dollar was trading at JPY105.51, improved from JPY105.45 at the same time Friday.

Brent oil was quoted at USD59.76 a barrel, up from USD59.62 a barrel at the London equities close Friday. Gold fetched USD1,815.23 an ounce, up from USD1,808.40.

A quiet economic calendar on Monday has German industrial production figures at 0700 GMT.

The UK corporate calendar on Monday has full-year results from property manager Inland Homes and trading statements from industrial and electronic products distributor Electrocomponents and consumer goods brand designer UP Global Sourcing Holdings.

Later in the week, the US earnings season picks up pace again, with social networking site Twitter reporting on Tuesday, soft drinks heavyweight Coca-Cola on Wednesday, and Walt Disney on Thursday.

By Eric Cunha; ericcunha@alliancenews.com;

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.